Dare Bioscience, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $5.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $573.0K | 9.8% |
| Other | $67.9K | 1.2% |
| Net Cash Flow | $5.2M | 89.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $5.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $573.0K | 9.8% |
| Other | $67.9K | 1.2% |
| Net Cash Flow | $5.2M | 89.0% |